Novartis appoints new comms head; Jerome Bettis and Sanofi want to know your 'AQ';

> Novartis ($NVS) has appointed Michael Willi as its group head of communications. More

> Four alcoholism meds worked to reduce addiction, a study found, which could dispel skepticism and spur greater use of the drugs. Report

> Amgen ($AMGN) is honoring four cancer survivors as part of its "Breakaway from Cancer" initiative. Release

> Novartis UK has launched a new mobile app that allows multiple sclerosis patients to track their symptoms and relapses. More

> A Johnson & Johnson ($JNJ) advertisement for a yogurt drink has been banned for exaggerating the product's health benefits. More

And Finally... Sanofi ($SNY) has signed on former NFL star Jerome Bettis to help it launch an anaphylaxis quiz during National Asthma and Allergy Awareness Month. Release

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

To take on AbbVie’s megablockbuster Humira, drugmakers need compelling data for physicians. Could Eli Lilly's Taltz be up to the challenge?

Why did GSK tweak its strict ethics measures for sales reps? When it first nixed incentive-based compensation, it thought other pharmas would, too.